Research & Development

Will Early-Career Research Transform Cancer Treatment in 2025?
Research & Development Will Early-Career Research Transform Cancer Treatment in 2025?

The field of cancer research has witnessed significant strides over the years, yet the journey to finding highly effective treatments remains complex and challenging. A pivotal aspect driving this progress is the contribution of early-career researchers, whose innovative ideas and fresh

Yale Study Finds Paxlovid Ineffective for Long COVID Symptoms
Research & Development Yale Study Finds Paxlovid Ineffective for Long COVID Symptoms

Ivan Kairatov is a seasoned biopharma expert, having dedicated numerous years to the advancement of innovation and technology in the field. He has substantial experience in research and development, making him a prominent figure to discuss the outcomes and implications of new clinical trials, such

Ultrasound and Bubbles: Singapore Trials Non-Invasive Tumor Treatment
Research & Development Ultrasound and Bubbles: Singapore Trials Non-Invasive Tumor Treatment

As a promising new frontier in cancer treatment, histotripsy represents a significant advancement in non-invasive medical procedures aimed at eliminating tumors. The technique utilizes bubbles generated via precise ultrasound waves to target and destroy specific cancer cells. Notably, histotripsy

Can Relacorilant and Nab-Paclitaxel Change Ovarian Cancer Treatment?
Research & Development Can Relacorilant and Nab-Paclitaxel Change Ovarian Cancer Treatment?

The recent results from the pivotal Phase 3 ROSELLA trial mark a significant development in the battle against platinum-resistant ovarian cancer. Corcept Therapeutics announced that the trial successfully demonstrated the efficacy of combining relacorilant with nab-paclitaxel chemotherapy,

Can CAR T-Cell Therapy Transform Treatment for Systemic Sclerosis?
Research & Development Can CAR T-Cell Therapy Transform Treatment for Systemic Sclerosis?

The medical landscape has been witnessing a groundbreaking shift with the advent of novel therapies aimed at tackling some of the most challenging conditions. One such development is the Phase 1/2 clinical trial of Cabaletta Bio's CAR T-cell therapy, rese-cel (resecabtagene autoleucel), targeting

Can AI-Powered Digital Twins Revolutionize ALS Clinical Trials?
Research & Development Can AI-Powered Digital Twins Revolutionize ALS Clinical Trials?

The rapid advancement of artificial intelligence (AI) has made significant strides in many sectors, and the realm of healthcare is no exception. Among the promising innovations is the use of AI-powered digital twins in clinical trials, particularly those targeting complex diseases like Amyotrophic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later